Álvaro Avezum

Researcher Next ID · RN-005928

Researcher · Medicine

São Paulo, Brazil

Not currently recruitingFunding unknown

Research interests

Medicine

Business, Management and Accounting

Acute Myocardial Infarction Research

Atrial Fibrillation Management and Outcomes

Antiplatelet Therapy and Cardiovascular Diseases

Blood Pressure and Hypertension Studies

Global Public Health Policies and Epidemiology

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
The Lancet · 2019 · https://doi.org/10.1016/s0140-6736(19)31149-3
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
New England Journal of Medicine · 2017 · https://doi.org/10.1056/nejmoa1709118
Apixaban versus Warfarin in Patients with Atrial Fibrillation
New England Journal of Medicine · 2011 · https://doi.org/10.1056/nejmoa1107039
Apixaban in Patients with Atrial Fibrillation
New England Journal of Medicine · 2011 · https://doi.org/10.1056/nejmoa1007432
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study
The Lancet · 2004 · https://doi.org/10.1016/s0140-6736(04)17018-9

No projects listed.